Who We Are

At Histoindex Pte. Ltd., we have been involved in the research & development, manufacturing and distribution of optical medical imaging equipment, as well as in the provision of related services, for the diagnosis of fibrosis and cancer.

Our aspiration is for patients to receive a new lease of life with personalised treatments, which will be a certainty as our technology paves the way for efficient and effective diagnosis.

Our systems - which function on revolutionary imaging technologies - have opened doors towards new medical standards that benefit clinical research, accelerate pharmaceutical drug development and provide an aid in clinical diagnostics.

In recognition of the company's recent achievements and efforts, especially in the area of Nonalcoholic Steatohepatitis (NASH), HistoIndex has been presented with the 2017 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Diagnostics New Product Innovation Award by Frost & Sullivan.

Click here to read more on HistoIndex by Frost & Sullivan's 2017 Best Practices Award.